04:44 PM EDT, 06/02/2025 (MT Newswires) -- Sernova Biotherapeutics ( SEOVF ) after trade Monday said it appointed Chief Executive Jonathan Rigby as interim chair of the board, effective immediately.

He will serve in this role until a new independent chair is named, the company added.

The company also said Chief Business Officer Modestus Obochi has left the company and thanked him for his contributions.

Sernova is continuing financing talks with GoldTrack Ventures and the Kingdom of Saudi Arabia, and views the potential investment as a promising partnership, according to the statement.

The company's shares closed down $0.005 to $0.17 on the Toronto Stock Exchange.